Management of oropharyngeal and tracheobronchial secretions in patients with neurologic disease

Journal of Palliative Medicine

Volumn 8, Issue 6, 2005, Pages 1150-1159

  Elman, Lauren B ^a   Dubin, Randy M ^b   Kelley, Mary ^a   McCluskey, Leo ^a,c  

^a Department of Neurology ^*

^b Department of Otorhinolaryngology   (United States)

^c Penn Neurological Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMITRIPTYLINE; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESIPRAMINE; GLYCOPYRRONIUM BROMIDE; GUAIFENESIN; HYOSCYAMINE; IPRATROPIUM BROMIDE; NORTRIPTYLINE; SALBUTAMOL; SCOPOLAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANHIDROSIS; BLURRED VISION; BONE MARROW DEPRESSION; BRONCHOSPASM; CONSCIOUSNESS DISORDER; CONSTIPATION; COUGHING; DROWSINESS; DRUG EFFICACY; DYSPHAGIA; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; HYPERSALIVATION; HYPOTENSION; INSOMNIA; MEDICAL LITERATURE; NERVOUSNESS; NEUROLOGIC DISEASE; OROPHARYNX; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHARYNX DISEASE; PHYSIOTHERAPY; POSTURAL DRAINAGE; RADIOTHERAPY; RASH; REVIEW; SIDE EFFECT; SKIN IRRITATION; SPIROMETRY; SUCTION; SYSTEMATIC REVIEW; TACHYCARDIA; TRACHEOBRONCHIAL TREE; TREATMENT FAILURE; TREATMENT INDICATION; TREMOR; URINE RETENTION; XEROSTOMIA;

BRONCHI; DEGLUTITION DISORDERS; HUMANS; NERVOUS SYSTEM DISEASES; OROPHARYNX; PALLIATIVE CARE; TRACHEA; UNITED STATES;

EID: 29444461142     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2005.8.1150     Document Type: Review

References (82)

1. Arglebe C: Biochemistry of human Saliva. Adv Otorhinolaryngol 1981;26:97.
2. Mandel I: Sialochemistry in diseases and clinical situations affecting salivary glands. Sialochemistry in diseases and clinical situations affecting salivery glands. Ann NY Acad Sci 1980;12:321.
3. Cummings C: Normal physiology. In: Otolaryngology: Head and Neck Surgery. St. Louis, MO: Mosby-Year Book, 1998.
4. Goetz C: Textbook of Clinical Neurology, 2nd ed. New York: Elsevier, 2003, pp. 1301-1302.
5. Smith LH, DeMyer WE: Anatomy of the brainstem. Semin Pediatr Neurol 2003;10:235-240.
6. Broniatowski M, Sonies BC, Rubin JS, Bradshaw CR, Spiegel JR, Bastian RW, Kelly JH: Current evaluation and treatment of patients with swallowing disorders. Otolaryngol Head Neck Surg 1999;120:464-473.
7. Domenech E, Kelly J: Swallowing disorders. Med Clin Noth Am 1999;83:97-113.
8. Plant RL: Anatomy and physiology of swallowing in adults and geriatrics. Otolaryngol Clin North Am 1998;31:477-488.
9. Logemann JA: Approaches to management of disordered swallowing. Baillieres Clin Gastroenterol 1991; 5:269-280.
10. Morris IR: Functional anatomy of the upper airway. Emerg Med Clin North Am 1988;6:639-669.
11. Logemann JA: Swallowing physiology and pathophysiology. Otolaryngol Clin North Am 1988;21: 613-623.
12. Cell B: The diaphragm and respiratory muscles. Chest Surg Clin North Am 1998;8:207-224.
13. Poole DC, Sexton WL, Farkas GA, Powers SK, Reid MB: Diaphragm structure and function in health and disease. Med Sci Sports Exerc 1997;29:738-754.
14. Epstein SK: An overview of respiratory muscle function. Clin Chest Med 1994;15:619-639.
15. Rakel RE: Textbook of Family Practice, 6th ed. Philadelphia: W.B. Saunders, 2002.
16. Bloem BR, Lagaay AM, Beek W: Prevalence of subjective dysphagia in community residents over 87. BMJ 1990;300:721.
17. Lindgren S, Janzon L: Prevalence of swallowing complaints and clinical findings among 50-79 year old men and women in an urban population. Dysphagia 1991;6:187-192.
18. Groher ME, Bukatman R: The prevance of swallowing disorders in two teaching hospitals. Dysphagia 1986;1:3.
19. Siebens H, Trupe E, Siebens A, Cook F, Anshen S, Hanauer R, Oster G: Correlates and consequences of eating dependency in institutionalized elderly. J Am Geriatr Soc 1986;34:192-198.
20. Finestone HM, Greene-Finestone LS; Rehabilitation medicine: 2. Diagnosis of dysphagia and its nutritional management for stroke patients, [see comments]. CMAJ 2003;169:1041-1044.
21. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW: Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil 1996;77:340-345.
22. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW: Malnutrition in stroke patients on the rehabilitation service and at follow-up: Prevalence and predictors. Arch Phys Med Rehabil 1995;76:310-316.
23. Gordon C, Hewer RL, Wade DT: Dysphagia in acute stroke. Br Med J (Clin Res Ed) 1987;295:411-414.
24. Barer DH: The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry 1989;52:236-241.
25. Mann G, Hankey GJ: Initial clinical and demographic predictors of swallowing impairment following acute stroke. Dysphagia 2001;16:208-225.
26. Mann G, Hankey GJ, Cameron D: Swallowing function after stroke: Prognosis and prognostic factors at 6 months [see comment]. Stroke 1999;30:744-748.
27. Gray GE: Nutrition and dementia [see comment]. J Am Diet Assoc 1989;89:1795-1802.
28. Morris HR, Wood NW, Lees AJ: Progressive supranuclear palsy (Steele-Richardson-Olszewski disease). Postgrad Med J 1999;75:579-584.
29. Cameron A, Rosenfeld J: Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurdegenerative disorders. Curr Opin Clin Nutr Metab Care 2002;5:631-643.
30. Rothstein RD: A systematic approach to the patient with dysphagia. Hosp Pract (Off Ed) 1997;323: 169-175.
31. Jones B: The pharynx. Disorders of function. Radiol Clin North Am 1994;32:1103-1115.
32. Hockstein NG, Samadi DS, Gendron K, Handler SD: Sialorrhea: A management challenge. Am Fam Physician 2004;69:2628-2634.
33. Comroe JH: Special acts involving breathing, In: Physiology of Respiration: An Introductory Text. Chicago: Year Book Medical Publishers, 1974, p. 230.
34. Ondo WG, Hunter C, Moore W: A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 2004;62: 37-40.
35. Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C: Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003;18:685-688.
36. Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, Reiners C, Toyka KV: Injections of botulinum A into the salivary glands to improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-123.
37. Pal PK, Calne DB, Calne S, Tsui JK: Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244-247.
38. Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R: Reduction of salivary flow with botulinum toxin: Extended report on 33 patients with drooling, salivary fistulas and sialadenitis. Laryngoscope 2004;114:1856-1860.
39. Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G: A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003;61:1279-1281.
40. Racette BA, Good L, Sagitto S, Perlmutter JS: Botulinum toxin B reduce sialorrhea in parkinsonism. Mov Disord 2003;18:1059-1061.
41. Dogu O, Apaydin D, Sevim S, Talas DU, Aral M: Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg 2004;106:93-96.
42. Ellies M, Rohrbach-Volland S, Arglebe C, Wilken B, Laskawi R, Hanefeld F: Successful management of drooling with botulinum toxin A in neurologically disabled children. Neuropediatrics 2002;33:327-330.
43. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche W: Botulinum toxin to reduce saliva flow. Selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscopy 2002;112: 82-86.
44. Suskind DL, Tilton A: Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
45. Porta M, Gamba M, Bertacchi G, Vaj P: Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-540.
46. Blasco PA: Management of drooling: 10 years after the Consortium on Drooling, 1990. [see comment]. Dev Med Child Neurol 2002;44:778-781.
47. Brei TJ: Management of drooling. Semin Pediatr Neurol 2003;10:265-270.
48. Castell JA, Stumacher SG, Castell DO: Approach to patients with oropharyngeal dysphagia. Gatroenterologist 1994;2:14-19.
49. Figgitt DP, Noble S: Botulinum toxin B: A review of its therapeutic potential in the management of cervical dystonia. Drugs 2002;62:705-722.
50. Lew KM, Younis RT, Lazar RH: The current management of sialorrhea. Ear Nose Throat J 1991;70: 99-105.
51. Pryor JA: Physiotherapy for airway clearance in adultws. Eur Respir J 1999;14:1418-1424.
52. Lorin MI, Denning CR: Evaluation of postural drainage by measurement of sputum volume and consistency. Am J Phys Med 1971;50:215-219.
53. Gallon A: The use of percussion. Physiotherapy 1992;78:85-89.
54. Thomas J, DeHueck A, Kleiner M, Newton J, Crowe J, Mahler S: To vibrate or not to vibrate: Usefulness of the mechanical vibrator for clearing bronchial secretions. Physiother Can 1997;47:120-125.
55. Arens R, Gozal D, Omlin KJ: Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 1994;150:1154-1157.
56. Ward RJ, Danziger F, Bonica JJ, Allen GD, Bowes J: An evaluation of postoperative respiratory maneuvers. Surg Gynecol Obstet 1966;123:51-54.
57. Dail CW: "Glossopharyngeal breathing" by paralyzed patients. Calif Med 1951;75:217-218.
58. Dail CW, Affeldt JE, Collier CR: Clinical aspects of glossopharyngeal breathing. JAMA 1955;158:445-449.
59. Alvarez SE, Peterson M, Lunsford BR: Respiratory treatment of the adult patient with spinal cord injury. Phys Ther 1981;61:1737-1745.
60. Pryor JA, Webber BA, Hodson ME, Batten JC: Evaluation of the forced expiration technique as an adjunct to postural drainage in cystic fibrosis. Br Med J 1979;2:417-418.
61. West JB: Pulmonary Pathophysiology. The Essentials, 5th ed. Baltimore: Williams and Wilkins, 1997.
62. Konstan MW, Stern RC, Doershuk CF: Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994;124:689-693.
63. Cegla UH, Bautz M, Frode G, Werner T: Physiotherapie bei Patienten mit COAD and tracheobronchialer Instaabilität-vergleich zweier oszillierender PEP-systeme (RC-Cornet®, VRP1 Destin). Pneumologie 1997; 51:129-136.
64. Falk M, Kelstrup M, Anderson LB: Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis 1984; 65:423-432.
65. Christensen EF, Nedergaard T, Dahl R: Long-term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy. Chest 1990;97:645-650.
66. McIlwaine PM, Wong LT, Peacock D, Davidson AG: Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997;131:570-574.
67. Perrin C, Unterborn JN, Ambrosio CD, Hill NS: Pulmonary complications of chronic neuromuscular diseases and their management [see comment]. Muscle Nerve 2004;29:5-27.
68. Vianello A, Corrado A, Arcaro G, Gallan F, Ori C, Minuzzo M, Bevilacqua M: Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil 2005;84:83-88; discussion 89-91.
69. Winck JC, Goncalves MR, Lourenco C, Viana P, Almeida J, Bach JR: Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway section encumbrance. Chest 2004;126:774-780.
70. Sancho J, Servera E, Vergara P, Marin J: Mechanical insufflation- exsufflation vs. tracheal suctioning via tracheostomy tubes for patients with amyotrophic lateral sclerosis: A pilot study. Am J Phys Med Rehabil 2003;82:750-753.
71. Servera E, Sancho J, Gomez-Merino E, Briones ML, Vergara P, Perez D, Marin J: Non-invasive management of an acute chest infection for a patient with ALS [see comment]. J Neurol Sci 2003;209:111-113.
72. Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK: Cough augmentation with mechanical insufflation/exsufflation in patients with neuromusclar weakness [see comment]. Eur Respir J 2003;21:502-508.
73. Hanayama K, Ishikawa Y, Bach JR: Amyotrophic lateral sclerosis. Successful treatment of mucous plugging by mechanical insufflation-exsufflation. Am J Phys Med Rehabil 1997;76:338-339.
74. Dean S, Bach JR: The use of noninvasive respiratory muscle aids in the management of patients with progressive neuromuscular diseases. Respir Care North Am 1996;2:223-240.
75. Bach JR: Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993;104:1553-1562.
76. Bach JR, Smith WH, Michaels J, Saporito L, Alba AS, Dayal R, Pan J: Airway secretion clearance by mechanical exsufflation for post-poliomyelitis ventilator-assisted individuals. Arch Phys Med Rehabil 1993;74:170-177.
77. Bach JR: Mechanical insufflation/exsufflation: has it come of age? A commentary [comment]. Eur Resp J 2003;21:385-386.
78. Borg M, Hirst F: The role of radiation therapy in the management of sialorrhea. Int J Radiat Oncol Biol Phys 1998;41:1113-1119.
79. Halama AR: Surgical treatment of oropharyngeal swallowing disorders. Acta Otorhinolaryngol Belg 1994;48:217-227.
80. Mandel L, Tamari K: Sialorrhea and gastroesophageal reflux. [see comment]. J Am Dent Assoc 1995;126: 1537-1541.
81. Shirley WP, Hill JS, Woolley AL, Wiatrak BJ: Success and complications of four-duct ligation for sialorrhea. Int J Pediatr Otorhinolaryngol 2003;67:1-6.
82. Nurse Practitioners' Prescribing Reference. Volume 12, Number 1. New York: Prescribing Preference Inc. 335., 2005.